ArticleThe Indian journal of medical research
First isolation of SARS-CoV-2 from clinical samples in India.
Abstract readLetter
In one paragraph
Article in The Indian journal of medical research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.
0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed.
- Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants.Scientific reports · 2022Trial
- Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial.Lancet (London, England) · 2021Trial
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial.The Lancet. Infectious diseases · 2021Trial
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial.The Lancet. Infectious diseases · 2021Trial
- Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial).BMJ (Clinical research ed.) · 2020Trial
- ICMR Institutes: From research to impact-National Institute of Virology, Pune.The Indian journal of medical research · 2026Article
- Advancing COVID-19 diagnostics: rapid detection of intact SARS-CoV-2 using viability RT-PCR assay.Microbiology spectrum · 2024Article
- SARS-CoV-2 Vaccines: Types, Working Principle, and Its Impact on Thrombosis and Gastrointestinal Disorders.Applied biochemistry and biotechnology · 2023Review
- Genomic evolution of the SARS-CoV-2 Variants of Concern: COVID-19 pandemic waves in India.EXCLI journal · 2023Review
- Article
- Detection and isolation of SARS-CoV-2 Eta variant from the international travelers and local residents of India.Journal of medical virology · 2022Article
- Isolation and Genomic Characterization of SARS-CoV-2 Omicron Variant Obtained from Human Clinical Specimens.Viruses · 2022Article
- Isolation of SARS-CoV-2 B.1.1.28.2 (P2) variant and pathogenicity comparison with D614G variant in hamster model.Journal of infection and public health · 2022Article
- Isolation and characterization of SARS-CoV-2 Beta variant from UAE travelers.Journal of infection and public health · 2022Article
- A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects.Frontiers in immunology · 2022Review
- Lack of evidence of viability and infectivity of SARS-CoV-2 in the fecal specimens of COVID-19 patients.Frontiers in public health · 2022Article
- Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152).Frontiers in immunology · 2022Article
- Prolonged Shedding of SARS-CoV-2 in Feces of COVID-19 Positive Patients: Trends in Genomic Variation in First and Second Wave.Frontiers in medicine · 2022Article
- Replication of SARS-CoV-2 in cell lines used in public health surveillance programmes with special emphasis on biosafety.The Indian journal of medical research · 2022Article
- A qualitative IgG ELISA for detection of SARS-CoV-2-specific antibodies in Syrian hamster serum samples.STAR protocols · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Prasad SarkaleMaximum Containment Laboratory, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Savita PatilMaximum Containment Laboratory, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Pragya D YadavMaximum Containment Laboratory, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Dimpal A NyayanitMaximum Containment Laboratory, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Gajanan SapkalDiagnostic Virology Group, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Shrikant BaradkarMaximum Containment Laboratory, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Rajen LakraMaximum Containment Laboratory, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Anita Shete-AichMaximum Containment Laboratory, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Sharda PrasadElectron Microscopy & Histopathology Group, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Atanu BasuElectron Microscopy & Histopathology Group, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Lalit DarDepartment of Microbiology, All India Institute of Medical Sciences, New Delhi 110 029, India.
Veena VipatInfluenza Group, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Sidhartha GiriDivision of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi 110 029, India.
Varsha PotdarInfluenza Group, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Manohar Lal ChoudharyInfluenza Group, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Ira PraharajDivision of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi 110 029, India.
Amita JainKing George's Medical University, Lucknow 226 003, Uttar Pradesh, India.
Bharati MalhotraDepartment of Microbiology, SMS Medical College, Jaipur 302 004, Rajasthan, India.
Pranita GawandeMaximum Containment Laboratory, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Kaumudi KaleleMaximum Containment Laboratory, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Nivedita GuptaDivision of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi 110 029, India.
Sarah S CherianBioinformatics & Data Management Group, ICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Priya AbrahamICMR-National Institute of Virology, Pune 411 001, Maharashtra, India.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
AnimalsBetacoronavirusChlorocebus aethiopsCoronavirus InfectionsCOVID-19High-Throughput Nucleotide SequencingHumansIndiaMicroscopy, Electron, TransmissionPandemicsPneumonia, ViralReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionSARS-CoV-2Vero Cells
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.